Can interleukin-10 be used as a true immunoregulatory cytokine?

European Cytokine Network

Volumn 11, Issue 2, 2000, Pages 153-160

  Wakkach, A ^a   Cottrez, F ^a   Groux, H ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Autoimmune diseases; IL 10; Regulatory T cells; Tolerance

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

ADOPTIVE IMMUNOTHERAPY; B LYMPHOCYTE; CYTOKINE RELEASE; DOWN REGULATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATORY DISEASE; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION;

ADJUVANTS, IMMUNOLOGIC; ANIMAL; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIFFERENTIATION; CYTOKINES; HUMAN; HYPERSENSITIVITY; IMMUNOSUPPRESSIVE AGENTS; IN VITRO; INTERLEUKIN-10; MICE; T-LYMPHOCYTES;

EID: 0033778539     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Identification of a novel thymocyte growth promoting factor derived from B cell lymphomas
2. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
3. The role of IL-10 in cross-regulation of Th1 and Th2 responses
4. Two types of mouse T helper cell: IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
5. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI
6. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI
7. Cytokine structural taxonomy and mechanisms of receptor engagement
8. Isolation of monoclonal antibodies specific for IL-4, IL-5, IL-6, and a new Th2-specific cytokine (IL-10), cytokine synthesis inhibitory factor, by using a solid phase radioimmunoadsorbent assay
9. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity with interferon gamma
10. Crystal struture of interleukin-10 reveals an interferon gamma-like fold
11. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes
12. IL-10, a novel growth cofactor for mature and immature T cells
13. A single amino acid determines the immunostimulatory activity of interleukin-10
14. Interleukin-10 (IL-10), a novel B cell stimulatory factor: Unresponsiveness of X chromosome-linked immunodeficiency B cells
15. Expression of IL-10 activity by Epstein-Barr virus protein BCRFI
16. Role of T cell derived cytokines in the downregulation of immune response in parasitic and retroviral infection
17. + T cells in human disease: Lymphokine patterns in leprosy
18. + T cells secreting Th1 or Th2 cytokines
19. + T cells: Their activation and effector functions
20. Interleukin-10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
21. Human B cell interleukin-10: B cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10
22. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin-10
23. IL-10 inhibits cytokine production by activated macrophages
24. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin-10
25. Ly1 B (B-1) cells are the main source of B cell derived IL-10
26. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10
27. Identification and induction of keratinocyte-derived IL-10
28. Production of IL-10 by melanoma cells: Examination of its role in immuno-suppression mediated by melanoma
29. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes
30. Interleukin-10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A
31. + T cells
32. IL-10: A novel cytotoxic T cell differentiation factor
33. Interleukin-10: A novel stimulatory factor for mast cells and their progenitors
34. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens
35. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts
36. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic (NOD) mouse
37. A non-cytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
38. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes
39. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity
40. Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin-10 in the islets of Langerhans
41. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis diabetes in non-obese diabetic mice
42. + T and B lymphocytes
43. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10
44. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells
45. Interleukin-10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures
46. Viral interleukin-10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors
47. Interleukin-10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression
48. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation
49. + T cell clones and peripheral blood T cells
50. IL-10 and v-IL-10 strongly reduce antigen specific human T cell responses by diminishing the antigen presenting capacity of monocytes via down-regulation of class II MHC expression
51. IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
52. B7-B1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10
53. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
54. Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes
55. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells
56. Interleukin-10 inhibits T cell alloreaction induced by human dendritic cells
57. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation
58. Human interleukin-10 can directly inhibit T cell growth
59. Interleukin-10
60. Interleukin-10 protects mice against staphylococcal enterotoxin B-induced lethal shock
61. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses
62. High levels of interleukin-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
63. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation
64. + T cells in the pathogenesis of organ-specific autoimmune diseases
65. Cytokine regulation of T cell function: Potential for therapeutic intervention
66. T cell subsets in autoimmunity
67. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
68. Biology of disease. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis
69. Surface expression of alpha-4 integrin by CD4 T cells is required for their entry into brain parenchyma
70. The T lymphocyte in experimental allergic encephalomyelitis
71. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin-4 and prostaglandin E expression in the brain
72. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery
73. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
74. Interleukin-10 prevents experimental autoimmune encephalomyelitis in rats
75. Treatment of experimental autoimmune encepahlomyelitis with genetically modified memory T cells
76. Interleukin-10 regulation in normal subjects and patients with asthma
77. T cells subsets and cytokines in allergic and non-allergic children. II. Analysis of IL-5 and IL-10 mRNA expression of protein production
78. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma
79. Successful immunotherapy with T cell epitope peptides of bee venom phospholipase A2 induces specific T cell anergy in patients allergic to bee venom
80. Role of interleukin-10 in specific immunotherapy
81. Decreased release of histamine and sulfidoleukotrienes by human peripheral blood leukocytes after wasp venom immunotherapy is partially due to induction of IL-10 and IFN-gamma production of T cells
82. IgE versus IgG4 production can be differentially regulated by IL-10
83. + T cell subset inhibits antigen-specific T cell responses and prevents colitis
84. + T cells
85. T cells in inflammatory bowel disease: Protective and pathologic roles